Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19
NCT04361318
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
COMBINATION_PRODUCT:
Hydroxychloroquine plus Nitazoxanide
OTHER:
Standard care
Sponsor
Tanta University